New draft guidance for Alzheimer’s treatments

On 1 February 2016, the European Medicines Agency (“EMA”) launched a public consultation concerning a “Draft guideline on the clinical investigation of medicines for the treatment of Alzheimer’s disease and other dementias“.To read more click here


Download PDF Share Back To Listing
Loading data